In 1986 Rita Levi Mondelcini and her colleague Stanley Cohen received the Nobel Price in Medicine for their discovery in Growth Factors. Since then a lot of research has led to understanding of the importance of Growth Factors in the human body and healing. Platelets’ regenerative potential was introduced when it was observed that they contain growth factors that are responsible for increase collagen production, cell mitosis, blood vessels growth, recruitment of other cells that migrate to the site of injury, and cell differentiation induction, among others.
Platelet Rich Plasma or PRP therapy has made headlines in our days because it is widely used in medicine.
One of the latest innovations is in oral surgery where they use platelet concentrates for in vivo tissue engineering applications: 1) platelet-rich plasma (PRP) and 2) platelet-rich fibrin (PRF). Platelet concentrates are a concentrated suspension of growth factors found in platelets, which act as bioactive surgical additives that are applied locally to induce wound healing.
Whitman et al , in 1997, were the first to introduce the use of platelet-rich plasma in oral surgical procedures, reporting great advantages because it enhances osteoprogenitor cells in the host bone and bone graft .On the other hand, PRF was first used in 2001 by Choukroun et al. , specifically in oral and maxillofacial surgery, and is currently considered as a new generation of platelet concentrate.
It consists of a matrix of autologous fibrin and has several advantages over PRP, including easier preparation and not requiring chemical manipulation of the blood, which makes it strictly an autologous preparation.
PRF membrane helps in wound healing, protecting the surgical site, promoting soft tissue repair .When mixed with bone graft, it may act as a “biological connector”, which attracts stem cell, favors the migration of osteoprogenitor cells to the centre of the graft, and provides a neo-angiogenesis.
Protocol for PRF preparation that we use in our clinic
The protocol tries to accumulate platelets and the released cytokines in a fibrin clot. Platelets are the second-most numerous corpuscles in the blood. Their lifetime is between 7 and 10 days.
1. PRF protocol requires only centrifuged blood. A blood sample is taken without anticoagulant in 10-mL glass tubes and immediately centrifuged.
The resultant product consists of the following three layers:
2. After this, it is necessary to put the PRF clot in a sterile cup for approximately 10 minutes to allow the release of the proper serum contained within. Mazor et al. reported that clot could be transformed into a membrane through the compression between two sterile gauzes or in a specific tool.
Advantages of using PRF
Some advantages are reported in the literature related to the use of PRF, such as the following:
Disadvantages of using PRF
PRF may present some disadvantages as follows:
In conclusion In vitro and in vivo studies have demonstrated safe and promising results, without contradictory findings, related to the use of PRF alone or in combination with other biomaterials. It has several advantages and possible indications to be used both in medicine and dentistry. Currently, platelet-rich fibrin seems to be an accepted minimally invasive technique with low risks and satisfactory clinical results.